Novartis shares fall as profit lags estimates; downside from Entresto patent loss to continue

Shares in Swiss drugmaker Novartis were seen down 3.3% in pre-market trade on Tuesday after the company reported third-quarter profitability below market expectations, even as higher sales from key me... ...